Brain Capital: a fresh approach to technologies and investing.
What happens when patients receive special treatment based on their rank or relationships? Two survivors share their stories.
There are several points along this pathway for a justice involved patient to be intercepted and diverted to mental health treatment.
D-cycloserine may help patients with anxiety disorders, or it might make their anxiety worse. Find out how to use it safely.
While there are no FDA-approved medications available for CUD, some studies show potential off-label utility in mitigating withdrawal and maintaining abstinence. Learn more in this CME article.
How can looking at the suffering of patients with schizophrenia through a psychodynamic lens help clinicians develop effective interventions and treatment plans?
Panelists discuss how faster-acting treatments like zuranolone might improve patient outcomes and quality of life, the initial signs to monitor for assessing effectiveness, barriers to accessing such therapies in underserved populations and strategies to increase accessibility, approaches to ensuring safety while addressing distress in patients with intrusive thoughts, effective strategies for managing sleep issues in postpartum depression (PPD), advice for the psychiatry community when treating PPD, and how to tailor advice for clinicians working with underserved populations.
How will the definition of assisted death (AD) as medical care impact its utilization?
“What we’re striving to do is conquer the unmet needs that are still here with treating ADHD, especially from a medication standpoint.”
In approximately half of patients with Huntington disease, symptoms of depression, irritability/aggression, executive dysfunction, psychosis, cognitive decline, and dementia present long before progressive motor symptoms.
The authors share evidence-based guidance for patient safety that minimizes suicide risk in medical settings.
The COVID-19 pandemic has disproportionately affected people of color due to legal, social, and economic inequities.
Bisexual individuals are at 4.5 to 6 higher risk of self harming than heterosexual individuals, according to this online study.
What are the connections between what we eat and disorders such as anxiety and depression?
In the final episode of this series, the experts share their conclusions and why examining the human side of fraud—in addition to the instruments of fraud—is key.
Gordon Lavigne, MEd, CEO of the Schizophrenia & Psychosis Action Alliance, talk about the joint FDA committee's vote on clozapine REMS.
Effective coordination of EHR system data between youth justice facilities and reentry programs can play a pivotal role in a youth’s successful reintegration into the community.
In this custom video series, Debra Stultz, MD, and Haramandeep Singh, MD, share advice for community-based psychiatrists on the management of narcolepsy.
This article provides a summary of key points discussed in a Case-Based Psych Perspectives Series, shared by Bryce Reynolds, MD, and Hannah Phillips-Hall, MSN, PMHNP-BC.
For older adults, hoarding disorder can have serious consequences. Examine this case study to learn more.
Cannabis use during pregnancy is associated with a host of negative outcomes.
The ambiguity of psychiatry naturally lends itself to a story, and creativity is all about telling a story.
A recent study serves as a model for future studies and lists several implications for the future of climate change psychiatric research.
Learn more about key findings on sex differences in cognition, exploring the possible causes and implications for clinical practice.
In this CME article, learn more about the controversies surrounding Lyme disease diagnosis and treatment, and common neuropsychiatric presentations of and treatment options.
In this CME article, learn more about a protocolized approach to the hospital management of pediatric patients with severe malnutrition related to eating disorders, including the utilization of a multidisciplinary care team and structured psychoeducation materials for families.
Lessons from the opioid epidemic should be applied to cases of methamphetamine abuse.
René S. Kahn, MD, PhD, discussed the potential artificial intelligence has to advance the field of psychiatry when diagnosing patients and allowing clinicians to focus on the clinical conversation.